Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolution. 2014

Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065; Pharmacokinetics group, Sawai Pharmaceutical Company, Ltd, Osaka 532-0003, Japan.

In vitro dissolution tests are performed for new formulations to evaluate in vivo performance, which is affected by the change of gastrointestinal (GI) physiology, in the GI tract. Thus, those environmental changes should be introduced to an in vitro dissolution test. Many studies have successfully shown the improvement of in vitro-in vivo correlations (IVIVC) by introducing those physiological changes into dissolution tests. The gastrointestinal simulator (GIS), a multicompartment in vitro dissolution apparatus, was developed to evaluate in vivo drug dissolution. A gastric-emptying rate along with transit rate are key factors to evaluate in vivo drug dissolution and, hence, drug absorption. Dissolution tests with the GIS were performed with Biopharmaceutical Classification System class I drugs at five different gastric-emptying rates in the fasted state. Computational models were used to determine in vivo gastric-emptying time for propranolol and metoprolol based on the GIS dissolution results. Those were compared with published clinical data to determine the gastric half-emptying time. In conclusion, the GIS is a practical tool to assess dissolution properties and can improve IVIVC.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008422 Materials Testing The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility. Biocompatibility Testing,Biocompatible Materials Testing,Hemocompatibility Testing,Testing, Biocompatible Materials,Testing, Hemocompatible Materials,Hemocompatibility Testings,Hemocompatible Materials Testing,Materials Testing, Biocompatible,Materials Testing, Hemocompatible,Testing, Biocompatibility,Testing, Hemocompatibility,Testing, Materials,Testings, Biocompatibility
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D004386 Duodenum The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers. Duodenums

Related Publications

Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
June 1983, Journal of pharmaceutical sciences,
Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
September 1981, Journal of pharmaceutical sciences,
Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
February 1979, Journal of pharmaceutical sciences,
Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
September 2016, Journal of pharmaceutical sciences,
Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
October 1996, Arzneimittel-Forschung,
Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
June 1975, The Journal of pharmacy and pharmacology,
Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
January 2020, AAPS PharmSciTech,
Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
May 2019, Molecular pharmaceutics,
Susumu Takeuchi, and Yasuhiro Tsume, and Gregory E Amidon, and Gordon L Amidon
September 1977, Journal of pharmaceutical sciences,
Copied contents to your clipboard!